[1]
|
Takahashi, A., Tokita, H., Takahashi, K., Takeoka, T., Murayama, K., Tomotsune, D., Ohira, M., Iwamatsu, A., Ohara, K., Yazaki, K., et al. (2011) A Novel Potent Tumour Promoter Aberrantly Overexpressed in Most Human Cancers. Sci-entific Reports, 1, Article No. 15. https://doi.org/10.1038/srep00015
|
[2]
|
Kim, J., et al. (2010) AMyc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs. Cell, 143, 313-324. https://doi.org/10.1016/j.cell.2010.09.010
|
[3]
|
Liang, H., Fu, Z., Jiang, X., Wang, N., Wang, F., Wang, X., Zhang, S., Wang, Y., Yan, X., Guan, W.X., et al. (2015) miR- 16 Promotes the Apoptosis of Human Cancer Cells by Targeting FEAT. BMC Cancer, 15, Article No. 448.
https://doi.org/10.1186/s12885-015-1458-8
|
[4]
|
Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., et al. (2002) Frequent Deletions and Down- Regulation of Micro-RNA Genes miR15 and miR16 at13q14 in Chronic Lymphocytic Leukemia. Proceedings of the National Academy of Sciences of the United States of America, 99, 15524-15529.
https://doi.org/10.1073/pnas.242606799
|
[5]
|
Liu, Q., Fu, H., Sun, F., Zhang, H., Tie, Y., Zhu, J., et al. (2008) miR-16 Family Induces Cellcycle Arrest by Regulating Multiple Cell Cycle Genes. Nucleic Acids Research, 36, 5391-5404. https://doi.org/10.1093/nar/gkn522
|
[6]
|
Li, Y., Kobayashi, K., Mona, M.M., Satomi, C., Okano, S., Inoue, H., Tani, K. and Takahashi, A. (2016) Immunogenic FEAT Protein Circulates in the Bloodstream of Cancer Pa-tients. Journal of Translational Medicine, 14, Article No. 275. https://doi.org/10.1186/s12967-016-1034-2
|
[7]
|
Clarke, S.G. (2013) Protein Methylation at the Surface and Bur-ied Deep: Thinking outside the Histone Box. Trends Biochem. Sci, 38, 243-252. https://doi.org/10.1016/j.tibs.2013.02.004
|
[8]
|
Jakobsson, M.E., Małecki, J., Halabelian, L., Nilges, B.S., Pinto, R., Kudithipudi, S., Munk, S., Davydova, E., Zuhairi, F.R., Arrowsmith, C., et al. (2018) The Dual Methyltransferase METTL13 Targets N Terminus and Lys55 of eEF1A and Modulates Codonspecific Translation Rates. Nature Commu-nications, 9, Article No. 3411.
https://doi.org/10.1038/s41467-018-05646-y
|
[9]
|
Garraway, L.A. and Lander, E.S. (2013) Lessons from the Cancer Genome. Cell, 153, 17-37.
https://doi.org/10.1016/j.cell.2013.03.002
|
[10]
|
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674.
https://doi.org/10.1016/j.cell.2011.02.013
|
[11]
|
Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz Jr., L.A. and Kinzler, K.W. (2013) Cancer Genome Landscapes. Science, 339, 1546-1558. https://doi.org/10.1126/science.1235122
|
[12]
|
Li, Y., Kobayashi, K., Murayama, K., Kawahara, K., Shima, Y., Su-zuki, A., Tani, K. and Takahashi, A. (2018) FEAT Enhances INSL3 Expression in Testicular Leydig Cells. Genes to Cells, 23, 952-962.
https://doi.org/10.1111/gtc.12644
|
[13]
|
Zhang, Z., Zhang, G., Kong, C., et al. (2016) METTL13 Is Downregulated in Bladder Carcinoma and Suppresses Cell Proliferation, Migration and Invasion. Scientific Reports, 6, Article No. 19261. https://doi.org/10.1038/srep19261
|
[14]
|
Liu, Z., Sun, T., Piao, C., Zhang, Z. and Kong, C. (2021) METTL13 Inhibits Progression of Clear Cell Renal Cell Carcinoma with Repression on PI3K/AKT/mTOR/HIF-1α Pathway and c-Mycexpression. Journal of Translational Medicine, 19, Article No. 209. https://doi.org/10.1186/s12967-021-02879-2
|
[15]
|
Wang, S.M., Ye, M., Zhou, J., Ni, S.M. and Wei, Q.C. (2017) FEAT Expression Correlates with Tumor Size, PR Status, HER2 Expression, Ki67 Index, and Molecular Subtype and Predicts Recurrence in Breast Cancer. Neoplasma, 64, 123-130. https://doi.org/10.4149/neo_2017_115
|
[16]
|
Liu, S., Hausmann, S., Carlson, S.M., Fuentes, M.E., Francis, J., Pillai, R., Lofgren, S.M., Hulea, L., Tandoc, K., Lu, J., et al. (2019) METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. Cell, 176, 491-504.E21. https://doi.org/10.1016/j.cell.2018.11.038
|
[17]
|
Li, L., Zheng, Y.L., Jiang, C., et al. (2019) HN1L-Mediated Transcriptional Axis AP-2γ/METTL13/TCF3-ZEB1 Drives Tumor Growth and Metastasis in Hepato-cellular Carcinoma. Cell Death & Differentiation, 26, 2268-2283.
https://doi.org/10.1038/s41418-019-0301-1
|
[18]
|
Su, X.F., Li, N., Meng, F.L., Chu, Y.L., Li, T. and Gao, X.Z. (2019) MiR-16 Inhibits Hepatocellular Carcinoma Progression by Targeting FEAT through NF-κB Signaling Pathway. European Review for Medical and Pharmacological Sciences, 23, 10274-10282.
|
[19]
|
Wang, X., Li, K., Wan, Y., Chen, F., Cheng, M., Xiong, G., Wang, G., Chen, S., Chen, Z., Chen, J., et al. (2021) Methyltransferase Like 13 Mediates the Translation of Snail in Head and Neck Squamous Cell Carcinoma. International Journal of Oral Science, 13, Article No. 26. https://doi.org/10.1038/s41368-021-00130-8
|
[20]
|
Yousaf, R., Ahmed, Z.M., Giese, A.P., Morell, R.J., Lagziel, A., Dabdoub, A., Wilcox, E.R., Riazuddin, S., Friedman, T.B. and Riazuddin, S. (2018) Modifier Variant of METTL13 Suppresses Human GAB1-Associated Profound Deafness. Journal of Clinical Investigation, 128, 1509-1522. https://doi.org/10.1172/JCI97350
|